FDA Approves First Medication for Obstructive Sleep Apnea
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
Zepbound Approved to Treat Obstructive Sleep Apnea
Jan 3, 2025 · Zepbound is the first medication for obstructive sleep apnea to receive FDA approval . This breakthrough for sleep apnea treatment received FDA approval in December 2024 and can be prescribed to adults who have both obesity and moderate to …
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...
Zepbound approved by FDA as first sleep apnea medication
6 days ago · On Dec. 20, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. Read the FDA press release announcing Zepbound’s approval for sleep apnea.
Tirzepatide for the Treatment of Obstructive Sleep Apnea and ...
Jun 21, 2024 · Obstructive sleep apnea is characterized by disordered breathing during sleep and is associated with major cardiovascular complications; excess adiposity is an etiologic risk factor....
Tirzepatide reduced sleep apnea severity by up to nearly two ...
Apr 17, 2024 · SURMOUNT-OSA (NCT05412004) was a multi-center, randomized, double-blind, parallel, placebo-master protocol comparing the efficacy and safety of tirzepatide to placebo in adults living with moderate-to-severe obstructive sleep apnea and obesity who were unable or unwilling to use positive airway pressure (PAP) therapy (Study 1) and those who ...
FDA approves weight-loss drug Zepbound for obstructive sleep ...
Dec 20, 2024 · The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as...
FDA approves weight loss drug Zepbound to treat sleep apnea : …
Dec 21, 2024 · The Food and Drug Administration on Friday authorized the use of Zepbound, made by Eli Lilly & Co., for adults with obesity and moderate to severe obstructive sleep apnea (OSA), a common...
FDA approves Zepbound® (tirzepatide) as the first and only ...
Dec 20, 2024 · Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also approved in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in ...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
Dec 23, 2024 · Zepbound, which was first approved for weight management in November 2023, now offers new hope for those with obesity and obstructive sleep apnea, Eli Lilly reported.
- Some results have been removed